$3.00Billion– No. of Holdings #82
| Ticker | $ Bought |
|---|---|
| alphatec hldgs inc | 63,389,500 |
| guardant health inc | 46,158,400 |
| generate biomedicines inc | 44,912,500 |
| rhythm pharmaceuticals inc | 27,015,300 |
| establishment labs hldgs inc | 26,323,200 |
| corvus pharmaceuticals inc | 25,643,400 |
| alphatec hldgs inc | 23,639,200 |
| damora therapeutics inc | 23,176,500 |
| Ticker | % Inc. |
|---|---|
| monte rosa therapeutics inc | 238 |
| irhythm holdings inc | 180 |
| argenx se | 173 |
| bright minds biosciences inc | 66.39 |
| mbx biosciences inc | 46.52 |
| caredx inc | 37.09 |
| zura bio ltd | 25.42 |
| inspire med sys inc | 25.27 |
| Ticker | % Reduced |
|---|---|
| edgewise therapeutics inc | -54.95 |
| cvs health corp | -48.48 |
| cg oncology inc | -47.35 |
| harrow inc | -47.03 |
| spyre therapeutics inc | -42.93 |
| repligen corp | -41.92 |
| guardant health inc | -41.87 |
| vera therapeutics inc | -33.25 |
| Ticker | $ Sold |
|---|---|
| ironwood pharmaceuticals inc | -50,467,700 |
| irhythm technologies inc | -72,800,000 |
| ventyx biosciences inc | -17,339,900 |
| relmada therapeutics inc | -7,642,300 |
| legend biotech corp | -28,221,600 |
| rapt therapeutics inc | -31,488,700 |
| terns pharmaceuticals inc | -23,243,000 |
| xencor inc | -7,029,830 |
BRAIDWELL LP has about 71.9% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 71.9 |
| Others | 28.1 |
BRAIDWELL LP has about 16.3% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 32.5 |
| UNALLOCATED | 28.1 |
| SMALL-CAP | 19.4 |
| LARGE-CAP | 16.3 |
| MICRO-CAP | 2.2 |
| NANO-CAP | 1.6 |
About 46.6% of the stocks held by BRAIDWELL LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 53.4 |
| RUSSELL 2000 | 39.4 |
| S&P 500 | 7.2 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
BRAIDWELL LP has 82 stocks in it's portfolio. About 27.7% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. was the most profitable stock for BRAIDWELL LP last quarter.
Last Reported on: 15 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACAD | acadia pharmaceuticals inc | 1.83 | 2,471,200 | 55,008,900 | added | 21.61 | ||
| ACHC | acadia healthcare company in | 0.50 | 645,900 | 15,107,600 | new | |||
| ACRS | aclaris therapeutics inc | 0.21 | 1,699,120 | 6,371,680 | new | |||
| ADPT | adaptive biotechnologies cor | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AGLE | spyre therapeutics inc | 1.57 | 932,823 | 47,051,600 | reduced | -42.93 | ||
| ALGN | align technology inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ANTX | elevance health inc formerly | 0.61 | 62,080 | 18,173,900 | new | |||
| ARGX | argenx se | 2.07 | 84,939 | 62,026,700 | added | 173 | ||
| ARWR | arrowhead pharmaceuticals in | 0.08 | 2,250,000 | 2,333,480 | new | |||
| ATEC | alphatec hldgs inc | 2.12 | 61,621,000 | 63,389,500 | new | |||
| ATEC | alphatec hldgs inc | 0.79 | 2,172,720 | 23,639,200 | new | |||
| AVAH | aveanna healthcare hldgs inc | 0.47 | 2,203,510 | 14,190,600 | new | |||
| BIIB | biogen inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BMRN | biomarin pharmaceutical inc | 0.94 | 497,020 | 28,076,700 | reduced | -17.37 | ||
| BSX | boston scientific corp | 0.72 | 346,467 | 21,740,800 | new | |||
| CDNA | caredx inc | 1.26 | 2,173,150 | 37,725,800 | added | 37.09 | ||
| CELC | celcuity inc | 0.11 | 29,198 | 3,332,660 | new | |||
| CLDX | celldex therapeutics inc new | 1.44 | 1,356,080 | 43,014,900 | reduced | -27.02 | ||
| CMPX | compass therapeutics inc | 0.35 | 1,965,110 | 10,395,400 | reduced | -29.48 | ||
| CNC | centene corp del | 0.36 | 330,000 | 10,804,200 | new | |||